Receive our newsletter – data, insights and analysis delivered to you
  1. Uncategorised
July 16, 2020

Study highlights variability in accuracy of Covid-19 antibody tests

By Chloe Kent

A peer-reviewed study by researchers at NSF International and Novateur Ventures has found significant variability in the accuracy of commercially available Covid-19 antibody tests.

Published independent performance data of five chemiluminescence immunoassay (CLIA), 15 enzyme-linked immunosorbent assay (ELISA) and 42 rapid diagnostic (RD) antibody tests that are currently on the market were reviewed for this study to understand their limits and potential. Overall, 13 top-performing antibody tests were identified based on independent evaluations of their sensitivity and specificity data (>95% accuracy).

Novateur Ventures advisor in scientific affairs Abdi Ghaffari said: “Granting FDA Emergency Use Authorization to several companies to accelerate the manufacturing of diagnostic tests was a good move, but it must be accompanied by informed and clear guidelines on preferred and minimally acceptable profiles of the Covid-19 antibody tests designed for a specific indication.”

Related Companies

Content from our partners
The added value of Qarad’s multilingual freephone service to their eIFU solution
Small and simple: how medical device manufacturers select materials
Precision wire: The future of bespoke medical treatment
Topics in this article:
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU